DE69913714T2 - Pharmazeutische zusammensetzung enthaltend entacapon oder nitecapon sowie ein vernetztes cellulosederivat - Google Patents

Pharmazeutische zusammensetzung enthaltend entacapon oder nitecapon sowie ein vernetztes cellulosederivat Download PDF

Info

Publication number
DE69913714T2
DE69913714T2 DE69913714T DE69913714T DE69913714T2 DE 69913714 T2 DE69913714 T2 DE 69913714T2 DE 69913714 T DE69913714 T DE 69913714T DE 69913714 T DE69913714 T DE 69913714T DE 69913714 T2 DE69913714 T2 DE 69913714T2
Authority
DE
Germany
Prior art keywords
nitecapone
pharmaceutical composition
composition containing
cellulose derivative
containing entacapone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69913714T
Other languages
English (en)
Other versions
DE69913714D1 (de
Inventor
Kari Vahervuo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Orion Oyj
Original Assignee
Orion Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22542186&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69913714(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Orion Oyj filed Critical Orion Oyj
Application granted granted Critical
Publication of DE69913714D1 publication Critical patent/DE69913714D1/de
Publication of DE69913714T2 publication Critical patent/DE69913714T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
DE69913714T 1998-09-14 1999-09-13 Pharmazeutische zusammensetzung enthaltend entacapon oder nitecapon sowie ein vernetztes cellulosederivat Expired - Lifetime DE69913714T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/152,263 US6599530B2 (en) 1998-09-14 1998-09-14 Oral compacted composition comprising catechol derivatives
PCT/FI1999/000740 WO2000015196A1 (en) 1998-09-14 1999-09-13 Pharmaceutical composition comprising entacapone or nitecapone as well as a cross-linked cellulose derivative

Publications (2)

Publication Number Publication Date
DE69913714D1 DE69913714D1 (de) 2004-01-29
DE69913714T2 true DE69913714T2 (de) 2004-10-07

Family

ID=22542186

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69913714T Expired - Lifetime DE69913714T2 (de) 1998-09-14 1999-09-13 Pharmazeutische zusammensetzung enthaltend entacapon oder nitecapon sowie ein vernetztes cellulosederivat

Country Status (39)

Country Link
US (1) US6599530B2 (de)
EP (1) EP1112065B1 (de)
JP (1) JP4619537B2 (de)
KR (1) KR100732187B1 (de)
CN (1) CN1151778C (de)
AR (1) AR021806A1 (de)
AT (1) ATE256454T1 (de)
AU (1) AU746889B2 (de)
BG (1) BG65041B1 (de)
BR (1) BR9913681A (de)
CA (1) CA2342634C (de)
CO (1) CO5130008A1 (de)
CZ (1) CZ293960B6 (de)
DE (1) DE69913714T2 (de)
DK (1) DK1112065T3 (de)
EA (1) EA003282B1 (de)
EE (1) EE04657B1 (de)
ES (1) ES2213381T3 (de)
GE (1) GEP20033062B (de)
HK (1) HK1039750B (de)
HR (1) HRP20010277B1 (de)
HU (1) HU228910B1 (de)
ID (1) ID29026A (de)
IL (1) IL141681A0 (de)
ME (1) ME00706B (de)
MY (1) MY124394A (de)
NO (1) NO331641B1 (de)
NZ (1) NZ510583A (de)
PE (1) PE20001060A1 (de)
PL (1) PL193454B1 (de)
PT (1) PT1112065E (de)
RS (1) RS49723B (de)
SI (1) SI1112065T1 (de)
SK (1) SK284049B6 (de)
TR (1) TR200100752T2 (de)
TW (1) TWI222367B (de)
UA (1) UA73925C2 (de)
WO (1) WO2000015196A1 (de)
ZA (1) ZA200102084B (de)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI109453B (fi) 1999-06-30 2002-08-15 Orion Yhtymae Oyj Farmaseuttinen koostumus
FI20000635A0 (fi) * 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
JP2008519811A (ja) 2004-11-10 2008-06-12 オリオン コーポレーション 下肢静止不能症候群の治療
AU2012216377C1 (en) * 2005-06-08 2013-10-10 Orion Corporation Oral dosage form
EA013161B1 (ru) * 2005-06-08 2010-02-26 Орион Корпорейшн Дозированная форма для перорального применения
WO2007069274A2 (en) * 2005-11-09 2007-06-21 Torrent Pharmaceuticals Limited Pharmaceutical composition comprising a compound having a catechol moiety and an alkalising agent
CA2642761A1 (en) * 2006-02-23 2007-08-30 Iomedix Sleep International Srl Compositions and methods for the induction and maintenance of quality sleep
GB2429645A (en) * 2006-03-10 2007-03-07 Sekhsaria Chemicals Ltd Solid pharmaceutical composition comprising a COMT inhibitor, a starch and a wetting agent
WO2007113371A1 (en) * 2006-03-31 2007-10-11 Iprbox Oy Pharmaceutical composition and preparation method thereof
CA2572004A1 (en) * 2006-12-08 2008-06-08 Bernard Charles Sherman Tablets comprising entacapone and crospovidone
EP1946756A1 (de) * 2007-01-17 2008-07-23 Revotar Biopharmaceuticals AG Verwendung von Entacapon für kosmetische, dermatologische und pharmazeutische Zusammensetzungen
RU2010136934A (ru) * 2008-02-06 2012-03-20 Вокхард Рисерч Сентер (In) Фармацевтические композиции энтакапона, микронизированного с сахарными спиртами
JP5466179B2 (ja) * 2008-02-06 2014-04-09 ウォックハート リサーチ センター 生物学的利用能が改善されたエンタカポン、レボドパ及びカルビドパの医薬組成物
NZ591326A (en) * 2008-08-22 2012-12-21 Wockhardt Research Center An extended release pharmaceutical composition of entacapone or salts thereof
JP5718937B2 (ja) * 2009-12-25 2015-05-13 イノファーマックス インコーポレイテッド パーキンソン病を治療するための医薬組成物及びその調製方法
WO2012147099A1 (en) 2011-04-25 2012-11-01 Suven Nishtaa Pharma Pvt. Ltd. Pharmaceutical compositions of levodopa, carbidopa and entacapone
EP2702991A4 (de) * 2011-04-26 2015-02-18 Innopharmax Inc Zusammensetzung von entacopon
WO2016083863A1 (en) 2014-11-28 2016-06-02 Bial - Portela & Ca, S.A. Medicaments for slowing parkinson's disease
CA2937365C (en) 2016-03-29 2018-09-18 F. Hoffmann-La Roche Ag Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same
EP3275433A1 (de) * 2016-07-29 2018-01-31 Som Innovation Biotech S.L. Zusammensetzung mit verzögerter freisetzung mit mikronisiertem tolcapon
CN106236720A (zh) * 2016-08-29 2016-12-21 海南通用康力制药有限公司 一种恩他卡朋的药物组合物及其制备方法
CN113274362A (zh) * 2021-03-31 2021-08-20 海南通用康力制药有限公司 恩他卡朋片的生产方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0301006B1 (de) * 1986-04-01 1992-05-06 The Upjohn Company Methylprednisolon/natriumcarboxymethylstärke-tablettenmischung
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
YU213587A (en) * 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5489614A (en) * 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
US5380535A (en) * 1991-05-28 1995-01-10 Geyer; Robert P. Chewable drug-delivery compositions and methods for preparing the same
TW430561B (en) * 1995-12-20 2001-04-21 Gea Farmaceutisk Fabrik As Rapid release tablet composition comprising tolfenamic acid or a pharmaceutically acceptable salt thereof as active ingredient and a method of preparing such tablet

Also Published As

Publication number Publication date
BR9913681A (pt) 2001-06-05
RS49723B (sr) 2007-12-31
JP2002524493A (ja) 2002-08-06
ATE256454T1 (de) 2004-01-15
SK284049B6 (sk) 2004-08-03
ID29026A (id) 2001-07-26
BG65041B1 (bg) 2007-01-31
HK1039750B (zh) 2005-02-18
NZ510583A (en) 2002-09-27
EA003282B1 (ru) 2003-04-24
HU228910B1 (en) 2013-06-28
SI1112065T1 (en) 2004-04-30
IL141681A0 (en) 2002-03-10
CN1319005A (zh) 2001-10-24
CZ2001792A3 (cs) 2001-08-15
US20020132009A1 (en) 2002-09-19
TR200100752T2 (tr) 2001-10-22
CZ293960B6 (cs) 2004-08-18
TWI222367B (en) 2004-10-21
ZA200102084B (en) 2002-06-13
HRP20010277B1 (en) 2010-10-31
PL346618A1 (en) 2002-02-25
KR20010075084A (ko) 2001-08-09
WO2000015196A1 (en) 2000-03-23
UA73925C2 (uk) 2005-10-17
ME00706B (me) 2007-12-31
YU19301A (sh) 2003-02-28
EE04657B1 (et) 2006-08-15
EE200100147A (et) 2002-06-17
DK1112065T3 (da) 2004-04-05
KR100732187B1 (ko) 2007-06-27
HUP0103454A2 (hu) 2002-01-28
SK3072001A3 (en) 2002-05-09
AU5748299A (en) 2000-04-03
US6599530B2 (en) 2003-07-29
NO20011278D0 (no) 2001-03-13
EP1112065A1 (de) 2001-07-04
NO331641B1 (no) 2012-02-13
EP1112065B1 (de) 2003-12-17
CA2342634C (en) 2008-01-29
CA2342634A1 (en) 2000-03-23
AU746889B2 (en) 2002-05-02
JP4619537B2 (ja) 2011-01-26
CO5130008A1 (es) 2002-02-27
PT1112065E (pt) 2004-04-30
PE20001060A1 (es) 2000-10-20
HK1039750A1 (en) 2002-05-10
GEP20033062B (en) 2003-09-25
DE69913714D1 (de) 2004-01-29
ES2213381T3 (es) 2004-08-16
CN1151778C (zh) 2004-06-02
AR021806A1 (es) 2002-08-07
BG105436A (en) 2001-11-30
MY124394A (en) 2006-06-30
EA200100354A1 (ru) 2001-08-27
PL193454B1 (pl) 2007-02-28
HUP0103454A3 (en) 2003-11-28
HRP20010277A2 (en) 2002-06-30
NO20011278L (no) 2001-03-13

Similar Documents

Publication Publication Date Title
DE69913714T2 (de) Pharmazeutische zusammensetzung enthaltend entacapon oder nitecapon sowie ein vernetztes cellulosederivat
EE04904B1 (et) Tiobensimidasooli derivaadid ja farmatseutiline kompositsioon
DE69624907D1 (de) Orale, pharmazeutische darreichungsformen, die einen protonenpumpeninhibitor und ein antacidum oder alginat enthalten
DE69600065T2 (de) Dermatologische und/oder pharmazeutische Zubereitung, ihre Herstellung und Anwendung
FI971354A (fi) Antineoplastiset kaakaouutteet, niiden valmistusmenetelmät ja käyttö
ATE222751T1 (de) Pharmazeutische aerosolzusammensetzung
DE69904312D1 (de) Pharmazeutische aerosolformulierung
IS5526A (is) 11ß-Halógen-7alfa-setin estratríen, aðferð til framleiðslu á lyfjasamsetningum sem innihalda fyrrnefnd estratríen og notkun þeirra til framleiðslu á læknislyfjum
DE69525148D1 (de) Pharmazeutische formulierung
NO20010078D0 (no) Fenoksyeddiksyrederivat og farmasöytisk sammensetning omfattende det samme
PT102291A (pt) Metanossulfonato de paroxetina processos para a sua preparacao composicao farmaceutica contendo o mesmo e sua utilizacao
NO975513D0 (no) 3-hydroksypyridin-2-karboksylsyreamidester, fremstilling og anvendelse som legemiddel
IT1312195B1 (it) Proiettile stabilizzato in rotazione e procedimento per la suafabbricazione
EE200100314A (et) Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
EE04348B1 (et) Sahhariidderivaadid, neid sisaldav farmatseutiline kompositsioon ja nende kasutamine
DE59910298D1 (de) Pharmazeutische levothyroxinzubereitung
DK1003383T4 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
DE69907675D1 (de) Ein substituiertes triazolo-pyridazin-derivat, davon hergestellte arzneimittel
DK0909271T3 (da) Indolyl-pyrrolylidenmethylpyrrolderivater og en fremgangsmåde til fremstilling deraf
DE69734163D1 (de) Kiefernnadelextrakt sowie dessen verwendung
IS4779A (is) Aðferð til að framleiða felódipín og aðferð til að framleiða lyfjablöndu
IT1289883B1 (it) Composizione farmaceutica antitubercolare e procedimento per la sua produzione
DE69508913T2 (de) Pharmazeutische polythioharnstoffe enthaltende formulierungen und methode zu ihrer verwendung
EE200100064A (et) Meetod mööbli ja dekoratiivsete elementide valmistamiseks
FI982018A (fi) Menetelmä lämpöelementin valmistamiseksi, lämpöelementti ja sen käyttö

Legal Events

Date Code Title Description
8364 No opposition during term of opposition